ÂÜÀòÂÒÂ×

Jason Keyes currently serves as a member of the Board of Directors and Audit Committee Chair at Actuate Therapeutics, Inc., and has held the position of Chief Financial Officer at Equillium, Inc. since March 2018, contributing to the company's focus on novel therapies for autoimmune and inflammatory diseases. Keyes has extensive experience on various boards, including Sesen Bio and Actuate Therapeutics, and has held senior financial leadership roles at Orexigen Therapeutics, Amylin Pharmaceuticals, and Amgen, where responsibilities included financial operations, strategic planning, and management of substantial budgets. Keyes holds an MBA in Finance from UCLA Anderson School of Management, along with a Master's and Bachelor's in Civil Engineering from Stanford University.